4.5 Review

Can noninvasive Brain Stimulation Improve Pain and Depressive Symptoms in Patients With Neuropathic Pain? A Systematic Review and Meta-Analysis

Journal

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Volume 64, Issue 4, Pages E203-E215

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jpainsymman.2022.05.002

Keywords

Noninvasive brain stimulation; neuropathic pain; depression; systematic review; meta-analysis

Funding

  1. Natural Science Foundation of Shandong Province [R2021QH062]
  2. Youth Scientific Research Fund Project of the Affiliated Hospital of Qingdao University [3471]

Ask authors/readers for more resources

This meta-analysis demonstrates that noninvasive brain stimulations (NIBS) have an analgesic effect on patients with neuropathic pain (NP), but do not provide beneficial effects in reducing concurrent depression symptoms.
Context. Noninvasive brain stimulations (NIBS) have been increasingly applied to the patients with neuropathic pain (NP), while the effectiveness of NIBS in the management of NP is still conflicting. Objectives. To examine the effectiveness of NIBS on pain and depression symptoms of patients with NP. Methods. A comprehensive literature retrieval was performed on MEDLINE, Embase, PsycINFO, PEDro, and CENTRAL from the establishment of the databases to June 2021. Randomized controlled trials comparing NIBS with sham stimulation were included. Results. A total of thirteen trials comprising 498 participants met the inclusion criteria. The pooled analysis found a significant effect on the improvement of pain scores at post-treatment, favoring NIBS over sham stimulation (SMD = -0.60; 95% CI: -1.00 to -0.20; P = 0.004). Subgroup analysis showed that only transcranial direct current stimulation (tDCS) (SMD = -0.38; 95% CI: -0.71 to -0.04; P = 0.030) and high-frequency repetitive transcranial magnetic stimulation (H-rTMS) (SMD = -0.95; 95% CI: -1.85 to -0.04; P = 0.040) had positive effects on pain reduction among all types of NIBS. The favorable effects of NIBS remained significant at follow-up visit (SMD = -0.51; 95% CI: -0.79 to -0.23; P = 0.000), while only H-rTMS was found in subgroup analyses to significantly improve pain scales of the patients (SMD = -0.54; 95% CI: -0.85 to -0.24; P = 0.000). Additionally, overall NIBS showed no beneficial effect over sham stimulation in reducing depression symptoms of NP patients either at post-treatment (SMD = -0.19; 95% CI: -0.39 to 0.01; P = 0.061) or at follow-up visit (SMD = -0.18; 95% CI: -0.45 to 0.10; P = 0.202). Conclusion. This meta-analysis revealed the analgesic effect of NIBS on patients with NP, while no beneficial effect was observed on reducing concomitant depression symptoms. The findings recommended the clinical application of NIBS in patients with NP. (c) 2022 Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available